Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 1, Issue 57
Abstract
The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogenic and antithrombotic effects, also an emphasis has been made on the safety of the drug.
Authors and Affiliations
V. V. Poltorak, N. A. Kravchun, M. Yu. Gorshunskaya, N. S. Krasova
Keywords
Related Articles
- EP ID EP226795
- DOI -
- Views 35
- Downloads 0
Structural and Functional Indexes of Cardiovascular System and Kidneys Against Insulin Resistance in Patients with Type 2 Diabetes Mellitus and Obesity
The article deals with the results of study of structural and functional indexes of the cardiovascular system and kidneys, pancreatic β-cells function, severity of insulin resistance in patients with type 2 diabetes mell...
Impact of the Fixed Combination of Iodine and Selenium on the Course of Autoimmune Thyroiditis in Iodine Deficiency Region
Recently, there were reports about the involvement of selenium deficiency in the development of autoimmune thyroiditis. A clinical study of the effect of the fixed combination of 150 µg of iodine and 75 µg of selenium ha...
Guarem in the Clinical Practice in Patients with Type 2 Diabetes Mellitus
The paper presents the results of Guarem usage in 35 obese patients with impaired glucose metabolism. Guarem has a sufficient hypoglycemic effect and lipid-lowering action. The main benefit of this drug is a significant...
Peculiarities of Cytokine Profile in Patients with Hypothyroidism and Concomitant Chronic Cholecystitis
The peculiarities of cytokine regulation in patients with hypothyroidism and concomitant chronic cholecystitis and its relationship with blood biochemical parameters and lipid profile parameters were investigated. The pr...
Using ultra-rapid insulin analogs in children and adolescents with type 1 diabetes mellitus
Background. The purpose of the study was a retrospective comparative analysis of using insulin analogues of the prolonged and ultra-short action and human genetically engineered insulins of middle and short action in chi...